NEDD9 Promotes Oncogenic Signaling in Mammary Tumor Development
Cancer Research , 69 (18), 7198–7206.
By: E. Izumchenko* , M. Singh, O. Plotnikova * , N. Tikhmyanova* , J. Little * , I. Serebriiskii, S. Seo * , M. Kurokawa * ...and 7 other authors , B. Egleston, A. Klein-Szanto, E. Pugacheva* , R. Hardy* , M. Wolfson* , D. Connolly * , E. Golemis
MeSH headings : Adaptor Proteins, Signal Transducing; Animals; Cell Movement / physiology; Cell Transformation, Neoplastic / genetics; Cell Transformation, Neoplastic / metabolism; Cell Transformation, Neoplastic / pathology; Female; Focal Adhesion Kinase 1 / metabolism; Mammary Neoplasms, Experimental / genetics; Mammary Neoplasms, Experimental / metabolism; Mammary Neoplasms, Experimental / pathology; Mammary Tumor Virus, Mouse / genetics; Mice; Mice, Inbred C57BL; Proteins / genetics; Proteins / metabolism; Signal Transduction
TL;DR:
It is shown that the Nedd9-null genetic background significantly limits mammary tumor initiation in the MMTV-polyoma virus middle T genetic model and suggests that NEDD9 expression may provide a biomarker for tumor aggressiveness.
(via
Semantic Scholar )
UN Sustainable Development Goal Categories
3. Good Health and Well-being
(OpenAlex)